In silico analysis of Trisindoline 1 compound against Mpro SARS-CoV-2 as novel potential drugs candidate
DOI:
10.29303/sjp.v2i2.87Downloads
Abstract
The novel coronavirus 2019 (SARS-CoV-2) is one of the viruses that can infect humans and cause high mortality worldwide. The protease (Mpro) is key SARS-CoV-2 an enzyme mediates the viral replication and the transcription. Mpro is currently used as the candidate for the SARS-CoV-2 vaccine because Mpro is one of the key enzymes in the viral life cycle that essential for interactions between the virus and host cell receptor during viral entry. The Mpro can be a target protein to design the novel drug of SARS-CoV-2. The drug design from natural products that are considered to have low toxicity is needed against the virus. The study aims to determines the potential pharmacology of Trisindoline 1 compound from the sponge Hyrtios altum against SARS-CoV-2 and to find the amino acid residues between interaction ligand-protein receptors. The methods of this study use the virtual screening of Auto Dock Vina and visualization the amino acid residue using Bio via Discovery Studio. The result of this study was the selected marine compound from Trisindoline 1 may have potential to developed as inhibitor of SARS-CoV-2.
Keywords: In Silico, Mpro, Sars Cov 2, Trisindoline 1, Sponges
Keywords:
In Silico, Mpro, Sars Cov 2, Trisindoline 1, SpongesReferences
Adhikari, S. P., Meng, S., Wu, Y.-J., Mao, Y.-P., Ye, R.-X., Wang, Q.-Z., Sun, C., Sylvia, S., Rozelle, S., Raat, H., & Zhou, H. (2020). Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: A scoping review. Infectious Diseases of Poverty 9(1), 29. 16(1):69. doi : https://doi.org/10.1186/s40249-020-00646-x
Aquilani R, Boselli M, D'Antona G, et al. (2014). Unaffected arm muscle hypercatabolism in dysphagic subacute stroke patients: the effects of essential amino acid supplementation. Biomed Res Int. doi: https://doi.org/10.1155/2014/964365
Aquilani R, Emilio B, Dossena M, Baiardi P, Testa A, Boschi F, Viglio S, Iadarola P, Pasini E, Verri M. (2015). Correlation of deglutition in subacute ischemic stroke patients with peripheral blood adaptive immunity: essential amino acid improvement. Int J Immunopathol Pharmacol 28(4):576–583.doi : https://doi.org/10.1177/0394632015608249
Bosch BJ, van der Zee R, de Haan CA, Rottier PJ. (2003) The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol ;77: 8801e11. doi : https://doi.org/10.1128/JVI.77.16.8801-8811.2003
Buondonno I, Sassi F, Carignano G, Dutto F, Ferreri C, Pili FG, Massaia M, Nisoli E, Ruocco C, Porrino P, Ravetta C, Riganti C, Isaia GC, D'Amelio P. (2020). From mitochondria to healthy aging: the role of branched-chain amino acids treatment: MATeR a randomized study. Clin Nutr. 39:2080–2091. doi : https://doi.org/10.1016/j.clnu.2019.10.013
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet ;395:507–13. doi: https://doi.org/10.1016/s0140-6736(20)30211-7
Chen YP, Cheng YF, Li XH, Yang WL, Wen C, Zhuang S, Zhou YM. (2017). Effects of threonine supplementation on the growth performance, immunity, oxidative status, intestinal integrity, and barrier function of broilers at the early age. Poult Sci. doi : https://doi.org/10.3382/ps/pew240
Chill L, Rudi A, Aknin M, Loya S, Hizi A, Kashman Y, et al. (2004). New sesterterpenes from Madagascan Lendenfeldia sponges. Tetrahedron, 60, 10619-10626. doi: https://doi.org/10.5681/bi.2011.029
Clive D and Jian Wang. (2003). Stereospecific Total Synthesis of the Antiviral Agent Hamigeran B—Use of Large Silyl Groups to Enforce Facial Selectivity and to Suppress Hydrogenolysis. Angew. Chem. Int. Ed. 42, 3406 – 3409. doi : https://doi.org/10.1002/anie.200351519
Crumpacker CS. (2004). Use of antiviral drugs to prevent herpes virus transmission. New England Journal of Medicine 350:67-68. doi : https://doi.org/10.1056/NEJMe038189
Cui J, Li F, Shi Z-L. (2019). Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol ;17:181–92. doi : https://doi.org/10.1038/s41579-018-0118-9
Detering C, Varani G. (2004). Validation of automated docking programs for docking and database screening against RNA drug targets. J. Med. Chem ;47:4188–4201. doi: https://doi.org/10.1021/jm030650o
Duan H.Q., Zhang Y.D., Fan K., Suo Z.W., Hu G., Mu X. (2007). Anti-inflammatory mechanism of esculetin. Chin. J. Vet. Med 43:45–46. doi: https://doi.org/10.3390/molecules22030387
Ge XY, Li JL, Yang XL, Chmura AA, Zhu G, Epstein JH, et al. (2013). Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature 2013;503:535e8. doi : https://doi.org/10.1038/nature12711
Guedes IA, de Magalhães CS, Dardenne LE. (2014). Receptor-ligand molecular docking. Biophysical Reviews 6: 75-87. doi : https://doi.org/10.1007/s12551-013-0130-2
Han DP, Penn-Nicholson A, Cho MW. (2006). Identifification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor. Virology ;350:15e25. doi : https://doi.org/10.1016/j.virol.2006.01.029
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Müller MA, Drosten C, Pöhlmann S. (2020). SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. doi : https://doi.org//10.1016/j.cell.2020.02.052
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet ;395:497e506. doi: https://doi.org/10.1016/S0140-6736(20)30183-5
In Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L., Peng C., Duan Y., Yu J., Wang L., Yang K., Liu F., Jiang R., Yang X., You T., Liu X., … Yang H. (2020). Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature, (7811), 289–293. doi : https://doi.org/10.1038/s41586-020-2223-y
Kannan S, Shaik Syed Ali P, Sheeza A, Hemalatha K. (2020). COVID-19 (Novel Coronavirus 2019)– recent trends. European Review for Medical and Pharmacological Sciences 24:2006-2011. doi : https://doi.org/10.26355/eurrev_202002_20378
Lin X, Li X, Lin X. (2020). A Review on Applications of Computational Methods in Drug Screening and Design. Molecules. doi : https://doi.org/10.3390/molecules25061375
Lira Simone P, Mirna H. R. Seleghim,a David E. Williams,b Frederic Marion,b Pamela Hamill,c François Jean,c Raymond J. Andersen,b Eduardo Hajdud and Roberto G. S. Berlinck. (2007). A SARS-Coronovirus 3CL Protease Inhibitor Isolated from the Marine Sponge Axinella cf. corrugata: Structure Elucidation and Synthesis. J. Braz. Chem. Soc., Vol. 18, No. 2, 440-443. doi : https://doi.org/10.1590/S0103-50532007000200030
Liu W., Morse J.S., Lalonde, T. Xu S. (2020). Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV. ChemBioChem 21, 730–738. doi: https://doi.org/10.1002/cbic.202000047
Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, et al. (2003). Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature ;426:450e4. doi : https://doi.org/10.1038/nature02145
Loya Shoshana, Amira Rudi, Yoel Kashman, and Amnon Hizi. (2002). Mode of inhibition of HIV-1 reverse transcriptase by polyacetylenetriol, a novel inhibitor of RNA- and DNA-directed DNA polymerases. Biochem J 15; 362(Pt 3): 685–692. doi : https://doi.org/10.1042/0264-6021:3620685
McConkey BJ, Sobolev V, Edelman M. (2002). The performance of current methods in ligand-protein docking. Current Science 83:845–855. Corpus ID: 15115681
Moitessier N, Englebienne P, Lee D, Lawandi J, Corbeil C. (2007). Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go. Br. J. Pharmacol ;153:S7– S26. doi : https://doi.org/10.1038/sj.bjp.0707515
Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ. (1998). Automated Docking Using a Lamarkian Genetic Algorithm and an Empirical Binding Free Energy Function. J. Comput. Chem ;19:1639–1662. doi: https://doi.org/10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
Muller W, Bohm M, Batel R, De Rosa S, Tommonaro G, Muller I, Schroder H. (2000). Application of cell culture for the production of bioactive compounds from sponges: synthesis of avarol by primmorphs from Dysidea avara. J. Nat. Prod 63:1077–1081. doi : https://doi.org/10.1021/np000003p
Nannou C, Ofrydopoulou A, Evgenidou E, Heath D, Heath E, Lambropoulou D. (2020). Antiviral drugs in aquatic environment and wastewater treatment plants: A review on occurrence, fate, removal and ecotoxicity. Sci Total Environ 699:134322. doi : https://doi.org/10.1016/j.scitotenv.2019.134322
Natalia Bailon-Moscoso, Gabriela Cevallos-Solorzano, Juan Carlos Romero-Benavides, and Maria Isabel Ramirez Orellana. (2017). Natural Compounds as Modulators of Cell Cycle Arrest: Application for Anticancer Chemotherapies. Current Genomics 18, 106-131. doi : https://doi.org/10.2174/1389202917666160808125645
Omrani AS, Saad MM, Baig K, Bahloul A, Abdul-Matin M, Alaidaroos AY, et al. (2014). Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. Lancet Infect Dis ;14:1090e5. doi : https://doi.org/10.1016/S1473-3099(14)70920-X
Park H, Lee J, Lee S. (2006). Critical assessment of the automated AutoDock as a new docking tool for virtual screening. Proteins ;65:549–554. doi : https://doi.org/10.1002/prot.21183
Patrick A. Holt, Jonathan B. Chaires, and John O. Trent. (2008). J Chem Inf Model; 48(8): 1602–1615. doi: https://doi.org/10.1021/ci800063v
Peiris JS, Guan Y, Yuen KY. (2004). Severe acute respiratory syndrome. Nature Medicine 10(12 Suppl):S88-97. doi : https://doi.org/10.1038/nm1143
Pillaiyar, Thanigaimalai, Manoj Manickam, Vigneshwaran Namasivayam, Yoshio Hayashi and Sang-Hun Jung. (2016). An Overview of Severe Acute Respiratory Syndrome−Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy. J. Med. Chem. 59, 6595−6628. doi: https://doi.org/10.1021/acs.jmedchem.5b01461
Rabaan AA, Al-Ahmed SH, Sah R, Tiwari R, Yatoo MI, Patel SK, Pathak M, Malik YS, Dhama K, Singh KP, Bonilla-Aldana DK. (2020). SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic virus–a review. Preprints, 2020040075.recent trends. European Review for Medical and Pharmacological Sciences 24:2006-2011. doi : https://doi.org/10.20944/preprints202004.0075.v1
Rohs R, Bloch I, Sklenar H, Shakked Z. (2005). Molecular flexibility in ab-initio drug docking to DNA: binding-site and binding-mode transitions in all-atom Monte Carlo simulations. Nucl Acids Res 33: 7048-7057. doi : https://doi.org/10.1093/nar/gki1008
Sagar, S., Kaur, M., and Minneman, K. P. (2010). Antiviral lead compounds from marine sponges. Mar. Drugs 8, 2619–2638. doi : https://doi.org/10.3390/md8102619
Sampangi-Ramaiah MH, Vishwakarma R, Shaanker RU. (2020). Molecular docking analysis of selected natural products from plants for inhibition of SARS-CoV-2 main protease. Curr Sci. 118(7):1087. Shaghaghi N. Molecular Docking study of novel COVID-19 Protease with low risk Terpenoides Compounds of Plants. ChemRxiv. doi: https://doi.org/10.18520/cs/v118/i7/1087-1092
Schoeman D, Fielding BC. (2019). Coronavirus envelope protein: current knowledge. Virol J 16, 69 (2019). doi : https://doi.org/10.1186/s12985-019-1182-0
Solerte SB, Gazzaruso C, Bonacasa R, Rondanelli M, Zamboni M, Basso C, Locatelli E, Schifino N, Giustina A, Fioravanti M. (2008). Nutritional supplements with oral amino acid mixtures increases whole-body lean mass and insulin sensitivity in elderly subjects with sarcopenia. Am J Cardiol 101(11A):69E–77E. doi: https://doi.org/10.1016/j.amjcard.2008.03.004
Uzair B, Mahmood Z, Tabassum S. (2011). Antiviral activity of natural products extracted from marine organisms. BioImpacts: BI. 1(4):203. doi : https://doi.org/10.5681/bi.2011.029
Varun, Sonam and Rita Kakkar. (2019). Isatin and its derivatives: a survey of recent syntheses, reactions, and applications. Med. Chem. Commun., 10, 351. doi : https://doi.org/10.1039/C8MD00585K
Vijayaraj, R., Altaff, K., Rosita, A. S., Ramadevi, S., & Revathy, J. (2020). Bioactive compounds from marine resources against novel corona virus (2019-nCoV): in silico study for corona viral drug. Natural Product Research, 1–5. doi : https://doi.org/10.1080/14786419.2020.1791115
Wellington K.D., Cambie R.C., Rutledge P.S., Bergquist P.R. (2000). Chemistry of sponges, 19: novel bioactive metabolites from Hamigera tarangaensis. J. Nat. Prod. 63:79–85. doi : https://doi.org/10.1021/np9903494
World Health Organization. (2020). WHO Coronavirus Disease (COVID-19). World. Health Organization. Retrieved from https://covid19.who.int/
Xuan-Yu Meng Hong-Xing Zhang, Mihaly Mezei, and Meng Cui. (2011). Molecular Docking: A powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des 1; 7(2): 146–157. doi: https://doi.org/10.2174/157340911795677602
Xu, H.; Lv, M. (2009). Developments of Indoles as Anti-HIV-1 Inhibitors. Curr. Pharm. Des. 15. 2120–2148. doi : https://doi.org/10.2174/138161209788489168
Zaki A.M., van Boheemen S., Bestebroer T.M. (2012). Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. The New England Journal of Medicine 367:1814–1820. doi : https://doi.org/10.1056/NEJMoa1211721
Zappe A, M.E. Snell B., M.J. Bossard. (2008). PEGylation of cyanovirin–N, an entry inhibitor of HIV. Advanced Drug Delivery Reviews 60 79–87. doi : https://doi.org/10.1016/j.addr.2007.05.016
Zhang, L., Lin, D., Kusov, Y., Nian, Y., Ma, Q., Wang, J., von Brunn, A., Leyssen, P., Lanko, K., Neyts, J., de Wilde, A., Snijder, E. J., Liu, H., & Hilgenfeld, R. (2020.). α-Ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication: Structure-based design, synthesis, and activity assessment. Journal of Medicinal Chemistry, 63(9), 4562–4578. doi : 10.1021/acs.jmedchem.9b01828
Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F. (2020). Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discovery. doi : https://doi.org/10.1038/s41421-020-0153-3
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W. (2020). A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 382, 727-733. doi : https://doi.org/10.1056/NEJMoa2001017
Zumla, A.; Chan, J.F.W.; Azhar, E.I.; Hui, D.S.C.; Yuen, K.-Y. (2016). Coronaviruses—Drug discovery and therapeutic options. Nat. Rev. Drug Discov. 15, 327–347. doi https://doi.org/10.1038/nrd.2015.37
License
Authors who publish with Sasambo Journal of Pharmacy (SJP), agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Lisensi Creative Commons Atribusi 4.0 Internasional. This license allows authors to use all articles, data sets, graphics and appendices in data mining applications, search engines, web sites, blogs, and other platforms by providing an appropriate reference. The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Sasambo Journal of Pharmacy
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
